Nufarm Ltd (NUF)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 3.010 |
|---|---|
| 52-week range | 1.790 – 3.370 |
| Return, 1 month / 3 months | −5.9% / +6.0% |
| Return, 1 year / 3 years | +40.7% / −34.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 38.6% |
| Worst drawdown (1 year) | -29.1% |
| Average daily value traded | 3.52M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nufarm is an Australian company that makes and supplies crop protection products for farmers. Its range includes herbicides, insecticides and fungicides used to control weeds, pests and diseases in crops. The company also offers seed treatments and other inputs for agricultural production. It serves growers and agricultural distributors in Australia and in overseas markets, with operations across several regions. Nufarm is based in Australia and works with farming customers who grow a variety of crops.
Nufarm Ltd trades under the code NUF on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nufarm Ltd (NUF) trades on the Australian Securities Exchange in Australia. It last closed at AUD 3.010 on 22 October 2026.
Its price-based Market X-Ray is 86 out of 100 (a strong price profile), ranking 17 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.7% and over the last three months it rose 6.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.6% | ||
| From 52-week high | -8.8% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.0% | ||
| 6-month return | 29.2% | ||
| 12-month return, skipping the last month | 49.5% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.1% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 3.52M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −5.9% |
| 3 months | +6.0% |
| 6 months | +29.2% |
| 1 year | +40.7% |
| 3 years | −34.7% |
| 5 years | −30.0% |
Signals
| 50-day / 200-day average | 3.139 / 2.627 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.094 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2024 | AUD 0.0400 |
| 22 Nov 2023 | AUD 0.0500 |
| 25 May 2023 | AUD 0.0500 |
| 24 Nov 2022 | AUD 0.0600 |
| 26 May 2022 | AUD 0.0400 |
| 25 Nov 2021 | AUD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.